Both in Pharmaceuticals
TuHURA Biosciences vs Cue Biopharma
Over the past year HURA returned −9.7% and CUE returned −23.4%; their daily moves had a correlation of -0.02.
HURA −9.7% CUE −23.4%Growth of $1, one year, split-adjusted
| Metric | HURA | CUE |
|---|---|---|
| Price | $2.09 | $18.95 |
| Market cap | $132.9M | $137.7M |
| Today | +18.47% | +11.21% |
| 1 month | −2.1% | −38.7% |
| 6 months | −22.2% | +8.9% |
| Year to date | +175.5% | +106.8% |
| 1 year | −14.9% | −23.0% |
| Revenue growth (YoY) | — | +166.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −1943.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.7× |
| Net cash | -$4.2M | $16.4M |
| Dividend yield | — | — |
| Volatility (60d) | 67.0% | 137.7% |
| Short % of float | 13.7% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).